Under physiological conditions, IL-4 functions as an anti-inflammatory cytokine that maintains immune homeostasis, yet within the tumor microenvironment, it can activate the Akt signaling pathway, promoting cancer cell survival. This evidence concerns the gene AKT1 and neoplasm.